178 related articles for article (PubMed ID: 18524069)
1. Constitutional law--substantive due process--en banc D.C. Circuit rejects fundamental right to experimental medications.--Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 495 F.3d 695 (D.C. Cir. 2007)(en banc), cert. denied, 128 S. Ct. 1069 (2008).
Harv Law Rev; 2008 Apr; 121(6):1685-92. PubMed ID: 18524069
[No Abstract] [Full Text] [Related]
2. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
Ochs A
Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
[No Abstract] [Full Text] [Related]
3. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
Simon LS; Green A
J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
[TBL] [Abstract][Full Text] [Related]
4. The proper focus for FDA regulations: why the fundamental right to self-preservation should allow terminally ill patients with no treatment options to attempt to save their lives.
Puckett A
SMU Law Rev; 2007; 60(2):635-65. PubMed ID: 17849632
[No Abstract] [Full Text] [Related]
5. Expanding access to investigational drugs for treatment use: a policy analysis and legislative proposal.
Winniford A
Health Matrix Clevel; 2009; 19(1):205-46. PubMed ID: 19459546
[No Abstract] [Full Text] [Related]
6. A new era of unapproved drugs: the case of Abigail Alliance v Von Eschenbach.
Jacobson PD; Parmet WE
JAMA; 2007 Jan; 297(2):205-8. PubMed ID: 17213404
[No Abstract] [Full Text] [Related]
7. Abigail Alliance v. Von Eschenbach: restricting access to potentially lifesaving drugs singe 2007.
Goodman AJ
J Contemp Health Law Policy; 2008; 25(1):107-41. PubMed ID: 19137749
[No Abstract] [Full Text] [Related]
8. Right to try?
Lieu CH; Sorkin A; Messersmith WA
J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
[No Abstract] [Full Text] [Related]
9. Charging for investigational drugs under an investigational new drug application. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
[TBL] [Abstract][Full Text] [Related]
10. Criminal procedure--substantive due process--D.C. Circuit holds that the government may forcibly treat incompetent criminal defendants with antipsychotic medication to render them competent to stand trial. --United States v. Weston, 255 F.3d 873 (D.C. Cir. 2001), petition for cert. filed (U.S. Sept. 5, 2001) (No. 01-6161).
Harv Law Rev; 2001 Dec; 115(2):737-43. PubMed ID: 11958231
[No Abstract] [Full Text] [Related]
11. Expanded access to investigational drugs for treatment use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
[TBL] [Abstract][Full Text] [Related]
12. Constitutional law -- free exercise clause -- Ninth Circuit rejects strict scrutiny for pharmacy dispensing requirement. -- Stormans, Inc. v. Selecky, 571 F.3d 960 (9th Cir. 2009).
Harv Law Rev; 2009 Dec; 123(2):596-603. PubMed ID: 20196268
[No Abstract] [Full Text] [Related]
13. Health care law--Medicaid--Third Circuit finds providers lack standing to enforce the Medicaid Act.--Pennsylvania Pharmacists Ass'n v. Houstoun, 283 F.3d 531 (3d Cir. 2002), cert. denied, 123 S.Ct. 100 (2002).
Harv Law Rev; 2003 Jan; 116(3):969-76. PubMed ID: 12530442
[No Abstract] [Full Text] [Related]
14. The right of access of the medically underserved to health care services.
Brandin PA
J Leg Med; 1981 Sep; 2(3):297-345. PubMed ID: 6976402
[No Abstract] [Full Text] [Related]
15. Expanding access to investigational new therapies.
Cohen C; Shevitz A; Mayer K
Prim Care; 1992 Mar; 19(1):87-96. PubMed ID: 1594704
[TBL] [Abstract][Full Text] [Related]
16. Right to experimental treatment: FDA new drug approval, constitutional rights, and the public's health.
Leonard EW
J Law Med Ethics; 2009; 37(2):269-79. PubMed ID: 19493072
[TBL] [Abstract][Full Text] [Related]
17. Beneficial and unusual punishment: an argument in support of prisoner participation in clinical trials.
Hoffman S
Indiana Law Rev; 2000; 33(2):475-515. PubMed ID: 16189915
[No Abstract] [Full Text] [Related]
18. Practical, legal, and ethical issues in expanded access to investigational drugs.
Darrow JJ; Sarpatwari A; Avorn J; Kesselheim AS
N Engl J Med; 2015 Jan; 372(3):279-86. PubMed ID: 25587952
[No Abstract] [Full Text] [Related]
19. Expanded access to Phase II clinical trials in oncology: a step toward increasing scientific validity and compassion.
Marcee AK
Food Drug Law J; 2008; 63(2):439-57. PubMed ID: 18561471
[No Abstract] [Full Text] [Related]
20. Minnesota's Right to Try law.
Hermer LD
Minn Med; 2016; 99(1):30-2. PubMed ID: 26897894
[No Abstract] [Full Text] [Related]
[Next] [New Search]
